BIOLIGANDS ApS: Financial statements 2024
CVR: 26603110
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
BIOLIGANDS ApS (CVR 26603110) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,904 and a net result of DKK -4,850 compared with DKK -4,345 the year before. Equity in the 2024 report amounted to DKK 69,828. The solvency ratio was 96.5%.
- Gross Profit
- DKK -5,904
- Profit/Loss
- DKK -4,850
- Equity
- DKK 69,828
- Total Assets
- DKK 72,328
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -6 t. | -5 t. | 70 t. | 0 |
| 2023 | - | -4 t. | -4 t. | 75 t. | - |
| 2022 | - | -5 t. | -5 t. | 79 t. | - |
| 2021 | - | -4 t. | -4 t. | 84 t. | - |
| 2020 | - | -5 t. | -5 t. | 89 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOLIGANDS ApS
BIOLIGANDS ApS is a Danish company of the type Anpartsselskab based in Odense SV, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named BIOLIGANDS ApS UNDER STIFTELSE. The management consists of Esben Nørgaard Flindt. The board consists of Rasmus Koefoed Petersen. The company's owners include Esben Nørgaard Flindt, Karsten Kristiansen and Hongbin Zhang. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -8,258 and a net result of DKK -7,129 compared with DKK -4,850 the year before. Equity in the 2025 report amounted to DKK 62,700.